Request Info


Ask for our annual reports or more information
Email Us

Email Alerts

Sign up for email alerts
Email Alerts
Investor Relations

News Releases

RSS RSS Feeds
News Release Search
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998
DateTitle  
4/26/2018Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance
CINCINNATI, April 26, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: GENERAL HIGHLIGHTS Reported record fiscal 2018 second quarter and first six months net revenues of $56.5 million and $108.7 million, respectively, increases of 4% and 8%, respectively, from the same periods of the prior fiscal year;   reported second quarter operating income of $7.7 million (including $4.9 million of costs associated with executive transition and realignment, and litigation ... 
 Printer Friendly Version
4/4/2018Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018
CINCINNATI, April 04, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its second quarter fiscal 2018 operating results before the NASDAQ market opens on Thursday, April 26, 2018. The release will be available shortly thereafter on Meridian’s website at www.meridianbioscience.com.  About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, mark... 
 Printer Friendly Version
3/21/2018Meridian Bioscience Realigns Organizational Structure
New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the Way for Future Growth Resulting Cost Savings to be Reinvested Back into the Business CINCINNATI, March 21, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the realignment of its business structure aimed at building a stronger, more sustainable organ... 
 Printer Friendly Version
1/25/2018Meridian Bioscience Reports First Quarter 2018 Operating Results, Declares Regular First Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance
CINCINNATI, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: GENERAL HIGHLIGHTS reported first quarter net revenues of $52.3 million, an increase of 12% from the same period of the prior fiscal year; reported first quarter operating income of $8.1 million (including $1.5 million of costs associated with transition to a new CEO and litigation costs), a decrease of 20% from the same period of the prior fiscal year; reported first quarter net ... 
 Printer Friendly Version
1/19/2018Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018
CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018 operating results before the NASDAQ market opens on Thursday, January 25, 2018. The release will be available shortly thereafter on Meridian’s website at www.meridianbioscience.com.  About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, mark... 
 Printer Friendly Version